Loading...
OTCM
ZRSEF
Market cap984mUSD
Apr 02, Last price  
7.45USD
Name

Zur Rose Group AG

Chart & performance

D1W1MN
OTCM:ZRSEF chart
P/E
—
P/S
0.28
EPS
—
Vol. 1Y
—
Shs. 5Y
22.87%
Rev. 5Y
-5.31%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.12b
+10.57%
488,269,000487,192,000523,306,000910,609,000915,554,000834,418,000879,535,000982,921,0001,207,108,0001,355,539,0001,476,930,0001,726,503,000930,969,000969,462,0001,017,045,0001,124,500,000
Net income
-134m
L+38.20%
3,921,0008,674,0006,156,000-15,464,0007,154,0003,445,000-12,769,000-36,238,000-38,971,000-52,358,000-135,695,000-225,735,000-171,115,00082,280,000-97,253,000-134,400,000
CFO
-88m
L+231.83%
13,960,0002,806,00020,809,0002,004,0007,200,00018,872,000-13,830,000-22,227,000-33,227,000-82,571,000-67,511,000-130,631,000-97,287,000-87,415,000-26,598,000-88,259,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

DocMorris AG, an enterprise headquartered in Frauenfeld, Switzerland, and founded in 1993, operates a dual business model encompassing e-commerce pharmacies and a wholesale distribution network for medical and pharmaceutical goods. Its market reach extends both within Switzerland and across international borders. The company's diverse offerings include consumer health, beauty, and personal care items, alongside services focused on medication management. Furthermore, DocMorris AG maintains physical pharmacy locations. It directly supplies its products to various clients, including medical professionals, online mail-order pharmacies, and individual consumers, utilizing several distinct brands such as Zur Rose, PromoFarma, TeleClinic, and DocMorris. The organization was initially known as Zur Rose AG before it changed its name to Zur Rose Group AG in May 2015.

Related entities

Subsidiaries
DocMorris Finance B.V.

Key people

Walter Oberhaensli
Non-Executive Chairman of the Board · since 2022
Walter Hess
Chief Executive Officer, Member of the Executive Board, Head Germany · since 2023
Daniel Wueest
Chief Financial Officer · since 2024
Kaspar Niklaus
Chief Operations Officer, Member of the Executive Board · since 2022
Pablo Ros Gomez
Chief Technology Officer · since 2024
Andrea Skersies
Chief Commercial Officer · since 2025
David Maso
Head - Europe, Member of the Executive Board · since 2021
Stefan Feuerstein
Non-Executive Independent Vice Chairman of the Board of Directors · since 2022
Andrea Belliger
Non-Executive Independent Member of the Board of Directors · since 2021
Christian Mielsch
Non-Executive Independent Member of the Board of Directors · since 2021
Hu Rongrong
Non-Executive Independent Member of the Board of Directors · since 2022
Florian Seubert
Non-Executive Independent Member of the Board of Directors · since 2021
URL
https://www.zurrosegroup.com/
IPO date
Jul 06, 2017
Employees
2,283
Domiciled in
CH
Incorporated in
CH
Headquarters & legal address
Walzmühlestrasse 49
Frauenfeld, TG 8500
CH
Previous name
Zur Rose Group AG
Other language
DocMorris Ltd
Other language
DocMorris SA

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT